Andrew Talal MD, MPH

Andrew H. Talal, MD, MPH, is a physician-scientist with more than 20 years’ experience in treating hepatitis C virus (HCV), especially among substance users. He is currently Professor of Medicine at SUNY, University at Buffalo, where he has recently completed a stepped wedge randomized controlled trial of facilitated telemedicine for HCV treatment integrated into opioid treatment programs compared to off-site referral. Dr. Talal was also appointed by the New York Governor to a task force to develop a statewide HCV elimination plan, and he also serves on the NYS HCV Guidelines committee. He also has active funding from the NIH to study factors leading to HCV elimination, and he is a practicing hepatologist.